The mark consists of the word "DUDE" with a curved line and a dot over the second "D". Below the word "DUDE" is the phrase "ACCESS SERVICES" and below that is the phrase "Darolutamide User Drug Experience".
Mark For: DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 90217844 |
Registration Number | 6308950 |
Mark Literal Elements | DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE |
Mark Drawing Type | - |
Mark Type | SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | NEW APPLICATION PROCESSING 2020-10-01 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Sondra Schol |
Attorney Docket Number | 2019-1637 00 |
2019-07-30 | Date of First Use |
2019-07-30 | Date of Use In Commerce |
2020-09-28 | Application Filed |
2020-10-01 | Location: NEW APPLICATION PROCESSING |
2020-10-01 | Status: Live/Pending |
2020-10-01 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
2020-10-01 | Transaction Date |
2021-03-30 | Trademark Registered |
Party: | Bayer Aktiengesellschaft |
Address | Kaiser-wilhelm-allee Leverusen GERMANY 51373 |
Legal Entity Type | Aktiengesellschaft |
Legal Entity State | GERMANY |
Application | MULTI | 2020-09-28 |
Drawing | JPEG | 2020-09-28 |
Specimen | JPEG | 2020-09-28 |
260121 | Circles that are totally or partially shaded. |
261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
IC 035. US 100 101 102. G & S: Business administration of patient reimbursement programs; Business administration of pharmaceutical reimbursement programs and services; Business management of reimbursement programs for others; Strategic business planning and consultation in the field of reimbursement support for pharmaceutical products; Business administration of support programs for patients to access co-pay assistance and other funding sources to pay for specialty medications. FIRST USE: 20190730. FIRST USE IN COMMERCE: 20190730
IC 036. US 100 101 102. G & S: Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs. FIRST USE: 20190730. FIRST USE IN COMMERCE: 20190730
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 36 |
U.S. Codes: | 100,101,102 |
Type Code | Type |
---|---|
D10000 | "ACCESS SERVICES" AND "DAROLUTAMIDE USER" AND "DRUG" |
D10000 | "ACCESS SERVICES" AND "DAROLUTAMIDE USER" AND "DRUG" |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2020-10-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.